AI Driven Drug Discovery Summit 2024 - Europe | Kisaco Research | TBA, London

Several high-profile partnerships between pharma and AI companies have materialized recently, but with commercial validation of approaches taking place, improving technologies will expedite this process. The summit will highlight key approaches to implementing novel AI technologies to expanding datasets. With this landscape rapidly evolving, the need to determine where and how AI can most add value has never been stronger. By uniting leaders from pharma, biotech, AI-technology companies and academia, this forum allows you to create a clear strategic vision and ambition regarding the use of AI to optimise drug discovery.

• This executive event reveals the latest technology upgrading the day-to-day tool kit of drug developers and data scientists spanning the pharmaceutical landscape.
• Understand how you can harness cutting-edge tools that provide discoverable, accessible, and transformable data analytics to guide your workflow, reducing costs, and informing decisions.
• Meet senior experts from start-ups to pharmaceutical giants and unlock the full potential of AI/ML platforms that are reshaping drug design, optimisation, and screening.
• Find out how to upgrade your presence and platform your AI services – based on your objectives we can create custom bespoke packages designed specifically for you.

2024 Speakers

SPEAKERS

Nick Brown
Head of Data Analytics, AstraZeneca

Alexander Hillisch
Head of Global Computational Drug Design, UCB

Emilie Louvet
Clinical Information Science Director, AstraZeneca

Soren Bertelsen
Director of Process Optimisation, Novo Nordisk

Richard Lewis
Director of Data Science, Novartis

Cathrin Pautsch
Senior Scientist Data & Analytics, Roche

Helena Andres-Terre
Associate Director, UCB

Bhavik Chouhan
Associate Director of Hepatic Safety, AstraZeneca

Philippe Moingeon
Associate Principal Informatician, Moingeon

Andrew Buchanan
Principal Scientist (ML/Biologics), AstraZeneca

Mazen Ahmad
Senior Data Scientist, Janssen

David J. Bearss
PHD Chief Executive Officer, Biolexis Therapeutics

Rabia Khan
Founder/CEO, Serna Bio

Kadi Liis Saar
Director, Machine Learning, Transition Bio

Claus Andersen
Senior Data Lead Project Director, Data Orchestration, Data Science, Development, Novo Nordisk